Cognitive impairment in COVID-19: associations, pathogenesis and treatment questions
Cognitive impairment (CI) can be neurological symptoms or complications of coronavirus disease 2019 (COVID-19). Among the pathogenetic mechanisms, the neurotropicity of the SARS- CoV-2 virus, endothelial dysfunction, coagulopathy, thrombus formation, systemic inflammatory reaction, the consequence...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2021-04-01
|
| Series: | Неврология, нейропсихиатрия, психосоматика |
| Subjects: | |
| Online Access: | https://nnp.ima-press.net/nnp/article/view/1551 |
| _version_ | 1797876334282670080 |
|---|---|
| author | V. A. Golovacheva G. R. Tabeeva I. V. Kuznetsov |
| author_facet | V. A. Golovacheva G. R. Tabeeva I. V. Kuznetsov |
| author_sort | V. A. Golovacheva |
| collection | DOAJ |
| description | Cognitive impairment (CI) can be neurological symptoms or complications of coronavirus disease 2019 (COVID-19). Among the pathogenetic mechanisms, the neurotropicity of the SARS- CoV-2 virus, endothelial dysfunction, coagulopathy, thrombus formation, systemic inflammatory reaction, the consequences of mechanical ventilation and drug sedation are considered. Treatment strategies for COVID-19 patients with CI have not yet been developed. The following tactics of patient management is advisable: prevention of re-infection, assessment and correction of the emotional state, treatment of cardiovascular diseases. The possibilities of vinpocetine in the treatment of CI after COVID-19 are discussed. |
| first_indexed | 2024-04-10T02:00:30Z |
| format | Article |
| id | doaj.art-12b44c586791463881e11b8165d7f5be |
| institution | Directory Open Access Journal |
| issn | 2074-2711 2310-1342 |
| language | Russian |
| last_indexed | 2024-04-10T02:00:30Z |
| publishDate | 2021-04-01 |
| publisher | IMA-PRESS LLC |
| record_format | Article |
| series | Неврология, нейропсихиатрия, психосоматика |
| spelling | doaj.art-12b44c586791463881e11b8165d7f5be2023-03-13T08:42:21ZrusIMA-PRESS LLCНеврология, нейропсихиатрия, психосоматика2074-27112310-13422021-04-0113212312910.14412/2074-2711-2021-2-123-1291122Cognitive impairment in COVID-19: associations, pathogenesis and treatment questionsV. A. Golovacheva0G. R. Tabeeva1I. V. Kuznetsov2Department of Nervous System Diseases and Neurosurgery, N.V. Sklifosovsky Clinical Medicine InstituteDepartment of Nervous System Diseases and Neurosurgery, N.V. Sklifosovsky Clinical Medicine InstituteUniversity Hospital №3, I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of RussiaCognitive impairment (CI) can be neurological symptoms or complications of coronavirus disease 2019 (COVID-19). Among the pathogenetic mechanisms, the neurotropicity of the SARS- CoV-2 virus, endothelial dysfunction, coagulopathy, thrombus formation, systemic inflammatory reaction, the consequences of mechanical ventilation and drug sedation are considered. Treatment strategies for COVID-19 patients with CI have not yet been developed. The following tactics of patient management is advisable: prevention of re-infection, assessment and correction of the emotional state, treatment of cardiovascular diseases. The possibilities of vinpocetine in the treatment of CI after COVID-19 are discussed.https://nnp.ima-press.net/nnp/article/view/1551covid-19cognitive impairmenttreatmentvinpocetine |
| spellingShingle | V. A. Golovacheva G. R. Tabeeva I. V. Kuznetsov Cognitive impairment in COVID-19: associations, pathogenesis and treatment questions Неврология, нейропсихиатрия, психосоматика covid-19 cognitive impairment treatment vinpocetine |
| title | Cognitive impairment in COVID-19: associations, pathogenesis and treatment questions |
| title_full | Cognitive impairment in COVID-19: associations, pathogenesis and treatment questions |
| title_fullStr | Cognitive impairment in COVID-19: associations, pathogenesis and treatment questions |
| title_full_unstemmed | Cognitive impairment in COVID-19: associations, pathogenesis and treatment questions |
| title_short | Cognitive impairment in COVID-19: associations, pathogenesis and treatment questions |
| title_sort | cognitive impairment in covid 19 associations pathogenesis and treatment questions |
| topic | covid-19 cognitive impairment treatment vinpocetine |
| url | https://nnp.ima-press.net/nnp/article/view/1551 |
| work_keys_str_mv | AT vagolovacheva cognitiveimpairmentincovid19associationspathogenesisandtreatmentquestions AT grtabeeva cognitiveimpairmentincovid19associationspathogenesisandtreatmentquestions AT ivkuznetsov cognitiveimpairmentincovid19associationspathogenesisandtreatmentquestions |